Stock listing
Aura Biosciences, Inc.
Selected listing: AURA · NASDAQ · USD · US
Aura Biosciences, Inc. (NASDAQ:AURA), Health Technology. Latest release Sep 2, 2026: Aura Biosciences to Participate in Upcoming Investor Conference.
- Ticker
- NASDAQ:AURA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Aura Biosciences, Inc.
Aura Biosciences, Inc. is a public company traded under the ticker AURA in the American market. Aura Biosciences focuses on developing innovative therapies for cancer treatment.
Latest news from Aura Biosciences, Inc.
Aura Biosciences to Participate in Upcoming Investor Conference
September 2, 2026
Aura Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 11, 2026
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
July 8, 2026
Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma
June 1, 2026
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(4)
May 20, 2026
Research Aura Biosciences, Inc.
Aura Biosciences, Inc. company profile
View the public company page for Aura Biosciences, Inc. on 6ix.
Aura Biosciences, Inc. news
Read company news and market updates connected to Aura Biosciences, Inc..
Aura Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Aura Biosciences, Inc..